457 related articles for article (PubMed ID: 33132768)
21. The effects of hydroalcoholic extract of spinach on prevention and treatment of some metabolic and histologic features in a rat model of nonalcoholic fatty liver disease.
Amirinejad A; Hekmatdoost A; Ebrahimi A; Ranjbaran F; Shidfar F
J Sci Food Agric; 2020 Mar; 100(4):1787-1796. PubMed ID: 31849065
[TBL] [Abstract][Full Text] [Related]
22. Antioxidant and anti-inflammatory effects of flavocoxid in high-cholesterol-fed rabbits.
El-Sheakh AR; Ghoneim HA; Suddek GM; Ammar el-SM
Naunyn Schmiedebergs Arch Pharmacol; 2015 Dec; 388(12):1333-44. PubMed ID: 26341793
[TBL] [Abstract][Full Text] [Related]
23. Atorvastatin and Vitamin E Accelerates NASH Resolution by Dietary Intervention in a Preclinical Guinea Pig Model.
Klaebel JH; Skjødt M; Skat-Rørdam J; Rakipovski G; Ipsen DH; Schou-Pedersen AMV; Lykkesfeldt J; Tveden-Nyborg P
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752351
[TBL] [Abstract][Full Text] [Related]
24. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
Karimi-Sales E; Ebrahimi-Kalan A; Alipour MR
Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
[TBL] [Abstract][Full Text] [Related]
25. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
Zhong FW; Li GX; Zeng L
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of oxidative stress, inflammation, and endothelial dysfunction in hypercholesterolemic rabbits by allicin.
El-Sheakh AR; Ghoneim HA; Suddek GM; Ammar ESM
Can J Physiol Pharmacol; 2016 Feb; 94(2):216-224. PubMed ID: 26618400
[TBL] [Abstract][Full Text] [Related]
27. Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.
Kiyici M; Gulten M; Gurel S; Nak SG; Dolar E; Savci G; Adim SB; Yerci O; Memik F
Can J Gastroenterol; 2003 Dec; 17(12):713-8. PubMed ID: 14679419
[TBL] [Abstract][Full Text] [Related]
28. Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.
Svop Jensen V; Fledelius C; Max Wulff E; Lykkesfeldt J; Hvid H
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673227
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
[TBL] [Abstract][Full Text] [Related]
30. Intervention Effects of Atorvastatin Combined with
Jiang QF; Huang MY; Wu KY; Weng JL; Deng RG; Xu XJ; Xu JP; Jiang T
Pharmacogn Mag; 2017; 13(51):430-438. PubMed ID: 28839368
[TBL] [Abstract][Full Text] [Related]
31. Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro.
Liu L; Zhao J; Li Y; Wan Y; Lin J; Shen A; Xu W; Li H; Zhang Y; Xu J; Peng J; Hong Z
Mol Med Rep; 2016 Jun; 13(6):4751-8. PubMed ID: 27081834
[TBL] [Abstract][Full Text] [Related]
32. Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease
Xing YW; Lei GT; Wu QH; Jiang Y; Huang MX
World J Gastroenterol; 2019 Feb; 25(8):955-966. PubMed ID: 30833801
[TBL] [Abstract][Full Text] [Related]
33. Icariin alleviates high-fat diet-induced nonalcoholic fatty liver disease via up-regulating miR-206 to mediate NF-κB and MAPK pathways.
Zhao H; Tian H
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23566. PubMed ID: 37888945
[TBL] [Abstract][Full Text] [Related]
34. Antihypercholesterolemic effect of Bacopa monniera linn. on high cholesterol diet induced hypercholesterolemia in rats.
Kamesh V; Sumathi T
Asian Pac J Trop Med; 2012 Dec; 5(12):949-55. PubMed ID: 23199712
[TBL] [Abstract][Full Text] [Related]
35. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
[TBL] [Abstract][Full Text] [Related]
36. Hypocholesterolaemic and antioxidant effects of yerba mate (Ilex paraguariensis) in high-cholesterol fed rats.
Bravo L; Mateos R; Sarriá B; Baeza G; Lecumberri E; Ramos S; Goya L
Fitoterapia; 2014 Jan; 92():219-29. PubMed ID: 24291756
[TBL] [Abstract][Full Text] [Related]
37. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
38. Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat.
Meng Y; Liu Y; Fang N; Guo Y
Pharm Biol; 2019 Dec; 57(1):98-104. PubMed ID: 30757944
[TBL] [Abstract][Full Text] [Related]
39. Curcumin attenuates diet-induced hypercholesterolemia in rats.
Arafa HM
Med Sci Monit; 2005 Jul; 11(7):BR228-234. PubMed ID: 15990684
[TBL] [Abstract][Full Text] [Related]
40. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
Jeong MJ; Kim SR; Jung UJ
Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
